Wang et al. found that the combined use of serum exosomal miR-122, exosomal miR-148a, and AFP, with an AUC of 0.931 (95% CI: 0.857–0.973), could be used to distinguish early-stage HCC from cirrhosis [62]. Here, AFP is linked to hepatocellular carcinoma.